To confirm that CCL20 can activate RCC cells, anti-CCL20 neutralizing antibody was added to ACHN and Caki-1 cells co-cultured with macrophage-like cells, and a significant inhibition of cell migration was observed in both the ACHN and Caki-1 cells (Figure 4B). The gene discussed is CCL20; the disease is renal cell carcinoma.